At a Glance
| 5-MeO-DiBF | 1,3-Butanediol | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 80–110 mg | — |
| Total Duration | 0.5–1 hrs | — |
| Routes | oral | oralsublingual |
5-MeO-DiBF, a Psychedelic, and 1,3-Butanediol, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 2 documented effects in common, with 30 effects unique to 5-MeO-DiBF and 11 unique to 1,3-Butanediol. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 5-MeO-DiBF | 1,3-Butanediol | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 80–110 mg | — |
| Total Duration | 0.5–1 hrs | — |
| Routes | oral | oralsublingual |
| Effects | 32 documented | 13 documented |
| Interaction | Low Risk & Synergy | |
| Level | 5-MeO-DiBF | 1,3-Butanediol |
|---|---|---|
| Threshold | 20 mg | — mg |
| Light | 50–80 mg | — mg |
| Common | 80–110 mg | — mg |
| Strong | 110–140 mg | — mg |
| Heavy | 140 mg | — mg |
| Level | Dose |
|---|
5-MeO-DiBF
1,3-Butanediol
Cross-tolerance exists; effects compound
No dangerous interactions recorded.
No dangerous interactions recorded.